Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …

Continue ›››

New Partnership Aims To Improve Kidney Cancer Treatment With AI

Owkin, a biotech startup that uses artificial intelligence (AI) for precision cancer therapy development is partnering with scientists from the …

Continue ›››

Cyclica's Chemical Probes for DCAF1

Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …

Continue ›››

Emerging AI Player in the Drug Discovery Race Promises to Screen Ultra-large Chemical Spaces Within Hours

Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the …

Continue ›››

AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine

Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. …

Continue ›››

How Pharmaceutical Industry Is Adopting Artificial Intelligence To Boost Drug Research

What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …

Continue ›››

The Many Ways Pharma Industry Is Benefitting from Artificial Intelligence

Artificial Intelligence (A.I.) has revolutionized many industries as we speak, which doesn't exclude pharmaceuticals. However, unlike other sectors concerning Information …

Continue ›››

2nd Annual SmartLabs & Laboratory Informatics Congress: Virtual

Oxford Global are proud to announce the SmartLabs & Laboratory Informatics Congress as part of our annual PharmaTec Series: Virtual. …

Continue ›››

18th Annual Pharma IT & Data Congress: Virtual

Oxford Global are proud to announce the PharmaIT & Data Congress as part of our annual PharmaTec Series: Virtual. This …

Continue ›››

4th Annual Artificial Intelligence in Drug Development: Virtual

Oxford Global are proud to announce the AI in Drug Development Congress as part of our annual PharmaTec Series: Virtual. …

Continue ›››

Annual Summit on Drug Discovery Chemistry

The Annual Summit on Drug Discovery Chemistry primarily works on the theme “Scientific Congress on pursuit of wisdom in Drug …

Continue ›››

7th Annual Peptides & Oligonucleotides Congress

With major developments in the peptide field and with more and more peptide and oligonucleotide therapeutics entering clinical trials, the …

Continue ›››